EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.17.4.4 | warfarin | 0.01 mM, 85% inhibition, 0.025 mM, 92% inhibition | Rattus norvegicus |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
1.17.4.4 | 0.065 | - |
styrene 1',2'-oxide | - |
Rattus norvegicus | |
1.17.4.4 | 0.805 | - |
allylbenzene 2',3'-oxide | - |
Rattus norvegicus |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
1.17.4.4 | microsome | - |
Rattus norvegicus | - |
- |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.17.4.4 | Rattus norvegicus | - |
- |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
1.17.4.4 | - |
Rattus norvegicus |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
1.17.4.4 | liver | - |
Rattus norvegicus | - |
EC Number | Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|---|
1.17.4.4 | 0.0167 | - |
- |
Rattus norvegicus |
1.17.4.4 | 0.108 | - |
substrate styrene 1',2'-oxide | Rattus norvegicus |
1.17.4.4 | 0.718 | - |
substrate allylbenzene 2',3'-oxide | Rattus norvegicus |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.17.4.4 | allylbenzene 2',3'-oxide + 1,4-dithiothreitol | - |
Rattus norvegicus | allylbenzene + oxidized dithiothreitol | - |
? | |
1.17.4.4 | styrene 1',2'-oxide + 1,4-dithiothreitol | - |
Rattus norvegicus | styrene + oxidized dithiothreitol | - |
? | |
1.17.4.4 | vitamin K 2,3-epoxide + dithiothreitol | - |
Rattus norvegicus | vitamin K + oxidized dithiothreitol | - |
? |